0000704172 false 0000704172 2022-04-07 2022-04-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 7, 2022

 

 

 

PHI GROUP, INC.

 

(Exact name of registrant as specified in its charter)

 

Wyoming   001-38255-NY   90-0114535
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

2323 Main Street, Irvine, CA   92614
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 714-793-9227

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Precommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Precommencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
Common Stock   PHIL   OTC Markets

 

 

 

 
 

 

SECTION 7 – REGULATION FD DISCLOSURE

 

Item 7.01 Regulation FD Disclosure

 

The information in this Item 7.01 of this Current Report is furnished pursuant to Item 7.01 and shall not be deemed “filed’ for any purpose, including for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act regardless of any general incorporation language in such filing.

 

I. Extension of Repurchase Date for the Company’s Common Stock

 

On April 7, 2022, the Company’s Board of Directors passed a corporate resolution to extend the time period for the repurchase of its own shares of common stock from the open market from time to time in accordance with the terms mentioned below and subject to liquidity conditions, satisfaction of certain open contractual obligations and the judgment of the Company’s Board of Directors and Management with respect to optimal use of potentially available funds in the future.

 

1. Purpose of Repurchase: To enhance future shareholder returns.
2. Details of Repurchase:

 

  a. Class of shares to be repurchased: Common Stock of PHI Group, Inc.
  b. Amount of repurchasable shares: As many as economically conducive and optimal for the Company.
  c. Total repurchase dollar amount: To be determined by prevalent market prices at times of transaction.
  d. Methods of repurchase: Open market purchase and/or negotiated transactions.
  e. Repurchase period: As soon as practical until June 30, 2023.
  f. The Company intends to fund the proposed share repurchase program with proceeds from long-term financing programs, future earnings, disposition of non-core assets and other potential sources, subject to liquidity, availability of funds, comparative judgment of optimal use of available cash in the future , and satisfaction of certain open contractual obligations.
  g. The share repurchase program will be in full compliance with state and federal laws and certain covenants with the Company’s creditors and may be terminated at any time based on future circumstances and judgment of the Company.

 

SECTION 9 – FINANCIAL STATEMENTS AND EXHBITS

 

Item 9.01 Financial Statements and Exhibits

 

The following is a complete list of exhibit(s) filed as part of this report.

 

Exhibit number(s) correspond to the number(s) in the exhibit table of Item 601 of Regulation S-K.

 

Exhibit No.   Description
     
10.1   Written Consent of Directors to Corporate Action Without Meeting of PHI Group, Inc. to Extend Repurchase of Common Stock
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: April 11, 2022

 

PHI GROUP, INC.  
(Registrant)  
     
By: /s/ Henry D. Fahman  
  Henry D. Fahman  
  Chairman and CEO  

 

 

 

EXHIBIT 10.1

 

WRITTEN CONSENT OF DIRECTORS TO CORPORATE ACTION

WITHOUT MEETING OF PHI GROUP, INC.

TO EXTEND REPURCHASE OF COMMON STOCK

 

A Wyoming Corporation

 

The undersigned members of Board of Directors of PHI GROUP, INC., a Wyoming corporation (the “Corporation”), constitute a quorum and by their signatures below, hereby approve the following resolutions and consent to their adoption, without a formal meeting of that Board of Directors (the “Board”), pursuant to Title 17-16-821 of the Wyoming Statues on this 7th day of April 2022.

 

WHEREAS, on December 27, 2021, the Company’s Board of Directors passed a corporate resolution to extend the time period for the repurchase of its own shares of common stock from the open market from time to time in accordance with the terms mentioned below:

 

1. Purpose of Repurchase: To enhance future shareholder returns.
2. Details of Repurchase:

 

  a. Class of shares to be repurchased: Common Stock of PHI Group, Inc.
  b. Amount of repurchasable shares: As many as economically conducive and optimal for the Company.
  c. Total repurchase dollar amount: To be determined by prevalent market prices at times of transaction.
  d. Methods of repurchase: Open market purchase and/or negotiated transactions.
  e. Repurchase period: Until March 31, 2022.
  f. The Company intends to fund the proposed share repurchase program with proceeds from the potential disposal of certain non-core assets and from other sources, subject to liquidity, availability of funds and satisfaction of contractual obligations.
  g. The share repurchase program must be in full compliance with state and federal laws and certain covenants with the Company’s noteholders.

 

WHEREAS, in light of the resultant adverse effects of the global coronavirus pandemic, the delays in the closing of various long-term financing programs with favorable costs of capital, as well as the current corporate priorities in connection with pending acquisitions and pivotal business development opportunities, its Board of Directors has determined that it is in the best interests of the Company and its shareholders to further extend the Common Stock repurchase period to a later date.

 

BE IT RESOLVED that, subject to liquidity conditions, satisfaction of certain open contractual obligations and the judgment of the Company’s Board of Directors and Management with respect to optimal use of potentially available funds in the future, the Corporation is authorized to repurchase its own shares of common stock from the open market from time to time in accordance with the terms mentioned below:

 

1. Purpose of Repurchase: To enhance future shareholder returns.
2. Details of Repurchase:

 

  a. Class of shares to be repurchased: Common Stock of PHI Group, Inc.
  b. Amount of repurchasable shares: As many as economically conducive and optimal for the Company.
  c. Total repurchase dollar amount: To be determined by prevalent market prices at times of transaction.
  d. Methods of repurchase: Open market purchase and/or negotiated transactions.
  e. Repurchase period: As soon as practical until June 30, 2023.

 

 
 

 

  f. The Company intends to fund the proposed share repurchase program with proceeds from long-term financing programs, future earnings, disposition of non-core assets and other potential sources, subject to liquidity, availability of funds, comparative judgment of optimal use of available cash in the future , and satisfaction of certain open contractual obligations.
  g. The share repurchase program will be in full compliance with state and federal laws and certain covenants with the Company’s creditors and may be terminated at any time based on future circumstances and judgment of the Company.

 

FURTHER RESOLVED that in addition to and without limiting the foregoing, each officer of the Company be and hereby is authorized and directed to take, or cause to be taken, such further action, and to execute and deliver, or cause to be delivered, for and in the name and on behalf of the Company, all such instruments and documents as such officer may deem necessary, appropriate or in the best interests of the Company to effectuate the intent of the foregoing resolutions and the transactions contemplated thereby (as conclusively evidenced by the taking of such actions or the execution and delivery of such instruments and documents, as the case may be) and all action heretofore taken by such officer in connection with the subject of the foregoing recitals and resolutions be, and it hereby is, approved, ratified and confirmed in all respects as the act and deed of the Company.

 

By their signatures below, the above resolutions have been duly authorized and adopted by the Company’s Board of Directors.

 

Dated: April 7, 2022

 

/s/ Henry D. Fahman   /s/ Frank Hawkins
Henry D. Fahman, Director   Frank Hawkins, Director
     
   
Tam Bui, Director